Details of the Drug

General Information of Drug (ID: DM9JQTQ)

• Drug Name: GS-5423

Indication

Disease Entry	ICD 11	Status	REF
Human immunodeficiency virus infection	1C62	Phase 1	[1]

• Drug Type: Antibody
• Cross-matching ID:
  PubChem CID: 12069231
  TTD ID: DEU08Q

References

• [1] ClinicalTrials.gov (NCT04811040) Study to Evaluate the Safety and Efficacy of GS-5423 and GS-2872 in Combination With Lenacapavir (GS-6207) in Virologically Suppressed Adults With HIV-1 Infection. U.S. National Institutes of Health.